Author:
Che Fengyuan,Heng Xueyuan,Zhang Haiyan,Su Quanping,Zhang Baoxue,Chen Yanying,Zhang Zhaohong,Du Yifeng,Wang Lijuan
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference67 articles.
1. Havranek O, Kleiblova P, Hojny J, Lhota F, Soucek P, Trneny M, Kleibl Z (2015) Association of Germline CHEK2 gene variants with risk and prognosis of Non-Hodgkin lymphoma. PLoS One 10:e0140819. doi:
10.1371/journal.pone.0140819
2. Glass S, Phan A, Williams JN, Flowers CR, Koff JL (2016) Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies. Discov Med 21:181–188
3. Grover NS, Park SI (2015) Novel targeted agents in Hodgkin and non-Hodgkin lymphoma therapy. Pharmaceuticals (Basel) 8:607–636. doi:
10.3390/ph8030607
4. Stienen JJ, Hermens RP, Wennekes L et al (2015) Variation in guideline adherence in non-Hodgkin’s lymphoma care: impact of patient and hospital characteristics. BMC Cancer 15:578. doi:
10.1186/s12885-015-1547-8
5. Zappasodi R, de Braud F, Di Nicola M (2015) Lymphoma immunotherapy: current status. Front Immunol 6:448. doi:
10.3389/fimmu.2015.00448
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献